Innovation in European healthcare – what can Sweden learn? - LIF

Elekta has established a model for integrated product
development in collaboration with the customer from the
early stages – though not in Sweden
”We have grown to a global position where we don’t really need
Sweden, but we are a Swedish company and we would like to have a
strong foothold in Sweden as our domestic market.”
Tomas Puusepp, CEO Elekta
”We partner with leading oncology clinics and work close
together with them in the product development – from the
early stages, to commercialisation and onwards.”
Måns Barsne Vice President R&D, Elekta
The Netherlands Cancer Institute
Christie Hospital, Manchester
Product development and clinical implementation
Princess Margaret Hospital, Toronto
”Most of the great Swedish medtech innovations were developed more than 30 years
ago. The counties are focused on production of healthcare, as they should, but the
efforts on clinical research is insufficient. They don’t see the need for continuous clinical
improvements.
You can compare this with the Princess Margaret Hospital in Toronto, which is building
up a cluster around our partnership and is embracing the idea that new companies will
be formed to support translational research and commercialisation for the benefit of the
patient”
25
Tomas Puusepp, CEO Elekta
”Given the infrastructure and availability of qualified
personnel, Stockholm is an excellent site for our product
development. We would invest a bigger portion of our
100 MEUR research budget if the Swedish healthcare
system was more interested in collaboration”
Måns Barsne Vice President R&D, Elekta